For every big story or spike in the value of a pharmaceutical stock prompted by a new cancer drug, there is probably a clinical ... used in a phase III trial to determine if adding another agent ...

Bayer has added another phase 3 trial into its registration ... patients who have often been overlooked and excluded from clinical trials, said Bayer. Asundexian (BAY2433334) is among an emerging ...